FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2017156172> ?p ?o ?g. }

• W2017156172 endingPage "760" @default.
• W2017156172 startingPage "753" @default.
• W2017156172 abstract "Background: Oxybutynin chloride and tolterodine tartrate are anticholinergic agents used to suppress involuntary bladder contractions in urinary incontinence. They act by inhibiting binding of acetylcholine to the muscarinic receptors in the detrusor muscle of the bladder. The same types of muscarinic receptors are found in the salivary glands; thus anticholinergic agents may decrease saliva production and cause dry mouth, a commonly cited reason for discontinuation of therapy. Objective: The primary objective of this study was to compare saliva output, which is an objective measure of dry mouth, in subjects taking immediate- or extended-release oxybutynin, tolterodine, or placebo. Methods: This was a single-site, single-dose, randomized, double-blind, 4-treatment, 4-period crossover study. Subjects were randomly assigned to 1 of 4 treatment sequences that included extended-release oxybutynin 10 mg, tolterodine 2 mg, immediate-release oxybutynin 5 mg, and placebo. Saliva output was measured objectively before dosing with each treatment and at 0.5, 1, 2, 3, 4, 6, 8, 10, and 12 hours after dosing. Results: Thirty-six healthy adult volunteers (22 women and 14 men) participated in the study. They ranged in age from 19 to 42 years (mean, 27 years). Thirty-one were white, 3 Asian, and 2 black. There were no significant differences in predose saliva output between the 4 study groups. With placebo, saliva output increased throughout the day. Saliva output was maintained at predose levels throughout the day with extended-release oxybutynin. Two hours after dosing with tolterodine and immediate-release oxybutynin, saliva output decreased nearly 0.5 g in specimens collected over 2 minutes.All 3 active treatments were associated with lower saliva output compared with placebo. Extended-release oxybutynin and tolterodine were similar with respect to area under the saliva concentration-time curve but were associated with significantly greater saliva output than was immediate-release oxybutynin (P < 0.01). There were no serious adverse events (AEs) in this study. AEs were similar between treatments, although the incidence of headache was higher in the active-treatment groups than with placebo. Conclusions: Objective assessment of saliva output in healthy adult volunteers indicated that extended-release oxybutynin and tolterodine had less impact on saliva output than did conventional immediate-release oxybutynin, suggesting that they may yield lower levels of dry mouth." @default.
• W2017156172 created "2016-06-24" @default.
• W2017156172 creator A5026819586 @default.
• W2017156172 creator A5053975805 @default.
• W2017156172 creator A5072528594 @default.
• W2017156172 creator A5076037136 @default.
• W2017156172 date "2001-05-01" @default.
• W2017156172 modified "2023-09-27" @default.
• W2017156172 title "A comparison of the effects of saliva output of oxybutynin chloride and tolterodine tartrate" @default.
• W2017156172 cites W12330039 @default.
• W2017156172 cites W1496249181 @default.
• W2017156172 cites W1982589773 @default.
• W2017156172 cites W2011917402 @default.
• W2017156172 cites W2024975356 @default.
• W2017156172 cites W2056759810 @default.
• W2017156172 cites W2068443208 @default.
• W2017156172 cites W2068456101 @default.
• W2017156172 cites W2069862149 @default.
• W2017156172 cites W2074323366 @default.
• W2017156172 cites W2088679190 @default.
• W2017156172 cites W2148567690 @default.
• W2017156172 cites W2164799400 @default.
• W2017156172 doi "https://doi.org/10.1016/s0149-2918(01)80024-2" @default.
• W2017156172 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11394733" @default.
• W2017156172 hasPublicationYear "2001" @default.
• W2017156172 type Work @default.
• W2017156172 sameAs 2017156172 @default.
• W2017156172 citedByCount "40" @default.
• W2017156172 countsByYear W20171561722012 @default.
• W2017156172 countsByYear W20171561722014 @default.
• W2017156172 countsByYear W20171561722018 @default.
• W2017156172 countsByYear W20171561722023 @default.
• W2017156172 crossrefType "journal-article" @default.
• W2017156172 hasAuthorship W2017156172A5026819586 @default.
• W2017156172 hasAuthorship W2017156172A5053975805 @default.
• W2017156172 hasAuthorship W2017156172A5072528594 @default.
• W2017156172 hasAuthorship W2017156172A5076037136 @default.
• W2017156172 hasConcept C126322002 @default.
• W2017156172 hasConcept C126894567 @default.
• W2017156172 hasConcept C142724271 @default.
• W2017156172 hasConcept C204787440 @default.
• W2017156172 hasConcept C27081682 @default.
• W2017156172 hasConcept C2777288759 @default.
• W2017156172 hasConcept C2777844464 @default.
• W2017156172 hasConcept C2778689640 @default.
• W2017156172 hasConcept C2778941218 @default.
• W2017156172 hasConcept C2781020410 @default.
• W2017156172 hasConcept C2910745098 @default.
• W2017156172 hasConcept C42219234 @default.
• W2017156172 hasConcept C504460877 @default.
• W2017156172 hasConcept C71924100 @default.
• W2017156172 hasConcept C87813604 @default.
• W2017156172 hasConcept C98274493 @default.
• W2017156172 hasConceptScore W2017156172C126322002 @default.
• W2017156172 hasConceptScore W2017156172C126894567 @default.
• W2017156172 hasConceptScore W2017156172C142724271 @default.
• W2017156172 hasConceptScore W2017156172C204787440 @default.
• W2017156172 hasConceptScore W2017156172C27081682 @default.
• W2017156172 hasConceptScore W2017156172C2777288759 @default.
• W2017156172 hasConceptScore W2017156172C2777844464 @default.
• W2017156172 hasConceptScore W2017156172C2778689640 @default.
• W2017156172 hasConceptScore W2017156172C2778941218 @default.
• W2017156172 hasConceptScore W2017156172C2781020410 @default.
• W2017156172 hasConceptScore W2017156172C2910745098 @default.
• W2017156172 hasConceptScore W2017156172C42219234 @default.
• W2017156172 hasConceptScore W2017156172C504460877 @default.
• W2017156172 hasConceptScore W2017156172C71924100 @default.
• W2017156172 hasConceptScore W2017156172C87813604 @default.
• W2017156172 hasConceptScore W2017156172C98274493 @default.
• W2017156172 hasIssue "5" @default.
• W2017156172 hasLocation W20171561721 @default.
• W2017156172 hasLocation W20171561722 @default.
• W2017156172 hasOpenAccess W2017156172 @default.
• W2017156172 hasPrimaryLocation W20171561721 @default.
• W2017156172 hasRelatedWork W1542102176 @default.
• W2017156172 hasRelatedWork W1559663349 @default.
• W2017156172 hasRelatedWork W1821426726 @default.
• W2017156172 hasRelatedWork W2012618608 @default.
• W2017156172 hasRelatedWork W2017156172 @default.
• W2017156172 hasRelatedWork W2069813136 @default.
• W2017156172 hasRelatedWork W2079785628 @default.
• W2017156172 hasRelatedWork W2404982990 @default.
• W2017156172 hasRelatedWork W2478482234 @default.
• W2017156172 hasRelatedWork W4292342649 @default.
• W2017156172 hasVolume "23" @default.
• W2017156172 isParatext "false" @default.
• W2017156172 isRetracted "false" @default.
• W2017156172 magId "2017156172" @default.
• W2017156172 workType "article" @default.